ENTITY
Celltrion Healthcare

Celltrion Healthcare (091990 KS)

214
Analysis
Health CareSouth Korea
Celltrion Healthcare Co.,Ltd develops and manufactures pharmaceutical biologics and chemically synthesized drugs. The Company specializes in the development of drugs for breast cancer, arthritis, leukemia, psoriasis, human rabies prevention, and influenza. Celltrion Healthcare markets its products to customers internationally.
more
Refresh
20 May 2019 21:29

One Equity Partners Plans to Sell 4.5% Stake of Celltrion Healthcare

It was announced after market close today that One Equity Partners plans to sell 6.5 million shares (4.5% of shares outstanding) of Celltrion...

Logo
556 Views
Share
20 May 2019 17:34

Celltrion Healthcare Placement - Past Deals Haven't Done Well

One Equity Partners plans to raise around US$337m via selling 6.5m shares of Celltrion Healthcare (091990 KS) . This is the second selldown by One...

Logo
480 Views
Share
bearishCelltrion Inc
28 Feb 2019 11:30

Biosimilar Battlefield: Unpacking Celltrion

Both Celltrion Inc (068270 KS) and Celltrion Healthcare (091990 KS) have reported preliminary 2018 results with some MD&A. As suspected, Q4's...

Share
24 Feb 2019 12:05

Celltrion Healthcare: Well, We Were Warned

Celltrion Healthcare (091990 KS) reported preliminary 2018 results that were dramatically short of expectations as the company cut shipments to...

Share
06 Feb 2019 11:41

Biosimilar Battlefield: The Remsima/Inflectra Warning

2019 marks an inflection point for Korean biosimilar companies Celltrion Healthcare (091990 KS), Celltrion Inc (068270 KS), and Samsung Biologics...

Share
x